Skip to content

Clinical trials

Cardiomyopathies trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: Brazil Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20081
20121
20141
20192
20201
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals4
Eidos Therapeutics, a BridgeBio company2
Instituto de Cardiologia do Rio Grande do Sul2
Federal University of Minas Gerais1
Fortaleza University1
Intellia Therapeutics1
Ionis Pharmaceuticals, Inc.1
Lexeo Therapeutics1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies14
Amyloidosis7
Alzheimer Disease3
Heart Diseases3
Heart Failure3
Amyloid Neuropathies, Familial2
Cardiomyopathy, Dilated2
Amyloidosis, Familial1
Chagas Cardiomyopathy1
Chagas Disease1

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.